Who Actually Needs a Flu Jab in 2026? The NHS List, the £22 Boots Queue and the 33% Number Nobody Puts on the Poster

Last winter the flu jab stopped roughly a third of the adults who had it from ending up in A&E with flu. A third. That’s the number the UK Health Security Agency published in November, and it’s the number that never makes it onto the poster in the pharmacy window. So before the autumn 2026 programme opens to everyone over 65 on 1 October, and before Boots starts taking £21.95 off anyone who fancies one, it’s worth getting straight on what a flu jab 2026 dose actually does, who it does it for, and who’s being sold a bit of a comfort blanket.

The short version: the vaccine is a far better deal for some people than others, the “super flu” you read about last Christmas wasn’t one, and the group with the strongest evidence for benefit is the group most parents forget to say yes to.

The 33% number, and why it’s not the scandal it sounds like

UKHSA measures flu vaccine effectiveness the sensible way: it looks at people turning up at hospital with confirmed flu and checks how many were vaccinated compared with people who turned up with something else. In the early weeks of the 2025/26 season, covering late September to early November, the vaccine was 32.8% effective against emergency department attendance in 18 to 64 year olds and 34.7% in the over-65s. Against actual admission, the over-65 figure crept up to 39%. The analysis covered 4,772 A&E attendances and 3,396 admissions, so it’s not a small sample.

Those are ordinary numbers. UKHSA’s own line is that effectiveness “typically” lands between 30% and 60%, and the whole-season figure for the winter before was 37.5% in working-age adults and 36.9% in pensioners. Flu vaccines have never been the 90%-plus story that the early Covid jabs were, and anyone who tells you otherwise is either selling something or hasn’t read the data.

But a third off your odds of a hospital trip is not nothing. NHS England estimates around 104,000 hospitalisations were avoided last winter from nearly 19 million jabs in England. If you’re 78 with a dodgy chest, a one-in-three reduction in the chance of a fortnight on a ward is the best £0 you’ll spend all year. If you’re 29, work from a spare bedroom in Leeds and haven’t seen a GP since 2019, the same percentage is being applied to a much smaller starting risk, and that’s where the honest conversation about paying for one starts. We’ll get there.

One more thing about the 33%. It’s protection against hospital-grade flu, not against feeling rough. Cochrane’s long-running review of healthy adults, last updated in 2018, put it bluntly: in a typical season you’d need to vaccinate 71 healthy adults to prevent one case of lab-confirmed flu, taking the risk from about 2.3% to 0.9%. The jab doesn’t promise you a winter without a cold. Colds aren’t flu, and most of what people call “flu” in December is a cold.

Flu jab 2026: what’s actually changed this autumn

Not a huge amount, but the details matter if you’ve got kids or an elderly parent.

The booking system opened on 17 August, earlier than the NHS has ever run it, partly because A&E saw a record 2.5 million attendances in July after a summer of heatwaves and the service wants winter demand flattened before it arrives. Pregnant women and children have been able to get vaccinated since 1 September. Everyone else on the eligible list, including the over-65s and adults in clinical risk groups, gets the green light from 1 October.

Two things are new. Community pharmacies can now vaccinate children aged 2 up to 18 who are in a clinical risk group (asthma on regular steroid inhalers, diabetes, heart conditions and so on), rather than families having to wait for the GP or the school session. And from 1 December, pharmacies will also run catch-up for school-aged kids who missed the school nurse. The second change is that rough sleepers and people using homeless hostels or night shelters, aged 16 and over, are on the national programme for the first time, on JCVI advice. Overdue, frankly.

All three strains in this year’s vaccine have been updated, which matters for reasons that come up in a moment.

The free list, and the two groups on it who tend not to bother

Here’s who the NHS will vaccinate for nothing this year, in plain terms. From 1 September: pregnant women; all children who were 2 or 3 on 31 August; every child from reception to Year 11; and any child from six months up who’s in a clinical risk group. From 1 October: everyone 65 and over; adults 18 to 64 with a long-term condition (the Green Book list is long, and includes asthma needing steroid inhalers, diabetes, chronic kidney disease, a BMI of 40 or more, and anyone on treatment that weakens the immune system); care home residents; carers, whether you get carer’s allowance or are simply the main person looking after someone elderly or disabled; people who live with someone immunocompromised; and frontline social care staff without occupational health cover.

If you think you qualify and nobody’s texted you, ring the practice or walk into a pharmacy. Don’t wait for the letter.

Two of those groups have consistently poor uptake, and they’re the two where the case is strongest. Pregnant women, first. Flu in pregnancy carries a higher risk of complications and the jab also passes some protection to the baby for the first few months of life, when they’re too young to be vaccinated themselves. And yet uptake in pregnancy has hovered well under half for years. If that’s you, this is the one health decision this autumn with the least ambiguity attached to it.

The second is the under-65 clinical risk group, which is enormous and mostly made up of people who don’t think of themselves as ill. If you’ve got a blue and a brown inhaler, you’re on the list. If you take metformin, you’re on the list. Being on the list doesn’t mean you’re frail; it means the NHS has decided the maths favours you.

Subclade K: the “super flu” that wasn’t

You’ll remember the headlines from last November. A drifted H3N2 strain, catchily named subclade K, drove an unusually early season, starting in teenagers and young adults before spreading to younger kids. The tabloids called it “Super-K” and “super flu”, and for about a fortnight every office in Britain had someone claiming they’d had it.

UKHSA’s verdict, published at the end of August, is worth quoting closely: flu activity “both start and decline early last year”, and there is, in its words, “no evidence” it caused more severe illness than a normal strain. The early-season effectiveness figures above were measured while subclade K was dominant, 84% of typed cases in fact, and the adult numbers held within the normal range. Children did better than usual.

Subclade K is one of the three strains the 2026/27 vaccine has been rebuilt around. Which is precisely why “I had flu last winter so I’m immune” doesn’t hold up: the virus you’ll meet this January has already moved on, and so has the jab.

Your kids get the best deal in the whole programme

This is the bit that ought to be on the poster. The nasal spray given to children was 74.8% effective against A&E attendance and 73.8% against admission in 2 to 17 year olds last autumn. That’s more than double the adult figure, in the age group that spreads flu around the house, the classroom and then to grandma.

The spray is a live, weakened virus squirted up each nostril. No needle, takes ten seconds, done in the school hall. A generation of parents still hesitates over the word “live”, so, for the record: it doesn’t give children flu, unvaccinated classmates aren’t at risk from being near a recently vaccinated child, and the only children who should avoid it are the severely immunosuppressed, who are offered the injection instead. Children who live with someone very immunosuppressed may also be offered the jab rather than the spray, which is a sensible precaution rather than a warning sign.

The consent form comes home in the book bag in September and gets lost under the fridge magnets. Sign it. If you’ve missed the school session, from 1 December a growing number of pharmacies will do the catch-up, and 2 and 3 year olds can go to some pharmacies directly.

The other thing about vaccinating children: it’s the closest thing the programme has to a lever on everyone else. UKHSA’s Dr Jamie Lopez Bernal said last November that high effectiveness in children “helps stop the spread of flu to others around them”. If your own risk is low but you’ve got a parent in a care home, the most useful jab in your family might not be yours.

Paying £22 at Boots: the healthy 30-year-old question

If you’re not on the free list, you can buy one. Boots charges £21.95 in almost 1,600 stores from September. Superdrug, Tesco, Asda and Lloyds all do it too, and last season the supermarkets were undercutting Boots by a wide margin, with Tesco under a tenner and Asda around £15. I couldn’t find every chain’s confirmed 2026 price when I checked this week, so ring ahead. Some employers hand out vouchers; check the intranet before you pay.

So, should a healthy adult under 65 with no conditions and no vulnerable contacts spend £22 on it?

Here’s where I’ll disagree with the general drumbeat. The evidence for personal benefit in that specific group is modest. One-in-71 to avoid a confirmed case. A third off a hospital risk that was already tiny. If you genuinely have nobody at risk in your life, the honest description of what £22 buys is a somewhat lower chance of a miserable week in bed, and that’s it. That’s a fair thing to buy. It’s also a fair thing not to.

But almost nobody actually fits that description. Most of us see a parent, a pregnant colleague, a mate on chemo or a baby at Christmas. Self-employed people can’t afford the week. Teachers and anyone working in a GP reception or a nursery are marinating in the stuff from October. For all of those, £22 is cheap. Cheaper, certainly, than the £30 tub of immune gummies the same shop will sell you on the way out, which has a fraction of the evidence behind it.

Timing is the other thing the marketing gets slightly wrong. Boots and the supermarkets want you in the chair in September because that’s when they’ve got stock and staff. But protection wanes over a season; waning within a single winter is well documented, UKHSA has published its own work on duration of protection across the 2022/23 and 2023/24 seasons, and it’s one reason the NHS holds most adults back to October. Flu usually peaks in December and January; last year it peaked early, which caught some people out, but early was November, not September. For a private jab, the first half of October is a perfectly good time. There’s no prize for being first in the queue.

Who should steer clear, or at least ask first

Fewer people than you’d think.

Egg allergy is the classic worry, and it’s mostly outdated. Nearly all flu vaccines are grown in eggs but contain so little egg protein that the NHS says most people with an egg allergy can have them in a normal setting; those with a history of anaphylaxis to egg can be given an egg-free (cell-grown) version, so ask rather than skip. A previous serious reaction to a flu vaccine itself is the genuine reason not to have one. If you’ve got a fever on the day, they’ll ask you to come back, which is about not muddling up symptoms rather than any danger.

Severely immunosuppressed children, as above, get the injection, not the spray. Adults on immunosuppressants are the opposite case: they’re on the free list precisely because they need it more, though their response can be weaker, which is one more reason to vaccinate the people around them.

And the one that isn’t a reason at all: “it gave me flu last time”. It can’t. The injected vaccine contains no live virus. What people get is a sore arm, a day of feeling grotty, sometimes a mild temperature, which is the immune system doing the thing you paid it to do. If you got proper flu two days after your jab, you’d already caught it before the vaccine had time to work, which takes about a fortnight. Which, again, is an argument for October rather than the week before Christmas.

A couple of last practical points. The over-65 vaccine is a different product from the working-age one (adjuvanted or high-dose, to get a stronger response out of older immune systems), so don’t be surprised if your mum’s is a different brand. You can have the flu jab and the Covid autumn booster in the same appointment if you qualify for both; UKHSA published the Covid eligibility list on 9 September and it’s narrower than the flu one. And no, the jab does nothing for the low mood that arrives with the clocks going back on 25 October; that’s a different conversation, as is whether you need vitamin D from October.

The flu jab is a modest tool that the NHS is very good at delivering and the retail sector is quite good at overselling. For pregnant women, the over-65s, anyone with a long-term condition and every child from two to sixteen, it’s the easiest yes of the autumn. For the healthy adult with £22 and no one vulnerable to protect, it’s a reasonable buy rather than an essential one, and October beats September. If you’ve spent more than that on alcohol-free beer this month, you can probably stretch to it.

So who in your house is actually the priority this year: you, or the seven-year-old whose consent form is still under the fridge magnet?